VBIV VBI Vaccines Inc

VBI Vaccines Inc is a biopharmaceutical company. It is engaged in developing novel technologies that seek to expand vaccine protection in large underserved markets.

As of 05/25/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Canada
IPO date:  02/12/2013
Outstanding shares:  258,257,494
Average volume:  2,268,737
Market cap:   $240,618,507
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYVFL64
Valuation   (See tab for details)
PE ratio:   -2.97
PB ratio:   1.68
PS ratio:   527.67
Return on equity:   -56.62%
Net income %:   -16,087.72%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy